The pressure to control drug development costs has led many biopharmaceutical companies to turn to other partners for help in the form of asset transfer. Kendle is well positioned to assist. We have substantial experience, having previously acquired assets from some of our existing partners. In addition to assuming your physical assets, Kendle can help ensure you hold on to the unique knowledge and experience of staff you may no longer be able to retain.
We’d love to have them join us and help you keep your overhead under control. We’ll take good care of them while they continue to take good care of your business. Please talk to us today to find out more.
